– Partnership focuses on “kitted” tests in ex-U.S. markets, enabling accelerated access through a decentralized model – – Deal potentially worth $200+ million increases Roche’s investment in Freenome with $75 million equity instrument and R&D support through innovative applications and technology collaboration – Brisbane, CA —Freenome, an early cancer detection company developing blood-based screening tests, today announced […]

IRVINE, Calif. — Zymo Research, a global leader in next-generation sequencing (NGS), has entered a strategic partnership with biomodal, an omics-based life sciences technology and analytics company. As part of biomodal’s certified provider network, Zymo Research’s NGS Services division is now authorized to deliver services using biomodal’s duet multiomics solutions, enabling researchers to access comprehensive genetic […]

BUILT Biotechnologies, Inc., an emerging leader in DNA Manufacturing-as-a-Service, today announced expanded commercial and manufacturing capabilities and the onboarding of more than 50 new customers with large-scale DNA construction needs for genome engineering and beyond. “Researchers advancing ambitious genome engineering programs rely on high-fidelity, large-scale DNA,” said George McArthur, PhD, CEO of BUILT. “Our unrivaled […]

Cologne, Germany — BioEcho, an Admera Health company delivering innovative nucleic acid purification and laboratory solutions, proudly announces that it has successfully achieved ISO 9001:2015 recertification. This milestone underscores the company’s ongoing dedication to providing high-quality, reliable, and sustainable products to researchers and laboratory professionals worldwide, while also delivering faster and more effective operations. ISO 9001 […]

Männedorf, Switzerland – Tecan Group (SIX Swiss Exchange: TECN) today announced that Tania Micki, Chief Financial Officer and member of the Management Board since February 2020, will be leaving the company to pursue an external opportunity. She will continue in her role through May 2026 to ensure a smooth transition. Tecan will nominate her successor […]

BOSTON — Volta Labs, a leader in automation for genomics, and New England Biolabs® (NEB®), a world-renowned provider of life science reagents, today announced a co-development partnership to expand the portfolio of NEBNext® reagents available on the Callisto™ Sample Preparation Platform. The collaboration combines Volta’s fully automated NGS sample preparation system with NEB’s trusted, high-performance NEBNext NGS sample […]

Biotium’s new TyraMax™ Amplification Dyes and Kits are available with the widest selection of colors for spatial analysis. FREMONT, CA — Biotium, a leading innovator in life science reagents, is excited to introduce TyraMax™ Amplification Dyes and Kits. Designed for superior brightness, photostability, and stability in amplification buffer compared to competitor reagents, TyraMax™ dyes deliver […]

Streamlined, high-throughput sequencing of Influenza A virus with integrated indexing for Oxford Nanopore Technologies® platforms IPSWICH, MA – New England Biolabs (NEB®) today announces the release of the NEBNext Flu A Integrated Indexing Primer Module (NEB #E3436), designed to streamline and scale the sequencing of Influenza A virus from a range of species and sample types […]

PeptiSystems, a life science company developing advanced manufacturing solutions for peptide and oligonucleotide-based therapeutics, has announced a significant growth investment from Rubicon Healthcare Partners. The partnership will enable PeptiSystems to accelerate its global expansion and deliver scalable, next-generation manufacturing solutions to a rapidly growing biopharma market. Uppsala, Sweden — Rubicon Healthcare Partners is a growth-oriented […]

CHARLOTTESVILLE, Va. — BUILT Biotechnologies, Inc., an emerging leader in DNA Manufacturing-as-a-Service, today announced that it has been chosen as the preferred manufacturing partner for clients of Neochromosome, Inc. who require large-scale DNA builds. As Neochromosome sunsets its DNA services to focus on its antibody display and cell engineering platforms, the company is offering clients […]